Glazer Capital, LLC Spring Works Therapeutics, Inc. Call Options Transaction History
Glazer Capital, LLC
- $2.8 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SWTX
# of Institutions
277Shares Held
73.1MCall Options Held
12MPut Options Held
1.39M-
Vanguard Group Inc Valley Forge, PA7.13MShares$335 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$264 Million0.0% of portfolio
-
Fil LTD Hamilton, D03.01MShares$142 Million0.13% of portfolio
-
State Street Corp Boston, MA2.99MShares$141 Million0.01% of portfolio
-
Tig Advisors, LLC New York, NY2.61MShares$123 Million6.62% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.93B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...